Sotera Health Company $SHC Stake Increased by Invesco Ltd.

Key Points

• Invesco Ltd. has increased its stake in Sotera Health Company by 10.4%, bringing its total holdings to 306,398 shares valued at approximately $3.57 million.
• Sotera Health recently reported an earnings per share (EPS) of $0.20 for the last quarter, exceeding analysts' expectations of $0.17, and recorded a 6.4% year-over-year revenue growth.
• Analysts have upgraded Sotera Health's stock ratings, with Barclays and Goldman Sachs issuing strong buy recommendations and setting new target prices above the current market value.

Invesco Ltd. increased its holdings in Sotera Health Company (NASDAQ:SHC - Free Report) by 10.4% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 306,398 shares of the company's stock after purchasing an additional 28,892 shares during the period. Invesco Ltd. owned 0.11% of Sotera Health worth $3,573,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Farther Finance Advisors LLC grew its position in Sotera Health by 4,881.9% during the first quarter. Farther Finance Advisors LLC now owns 6,327 shares of the company's stock valued at $70,000 after acquiring an additional 6,200 shares during the period. Teacher Retirement System of Texas acquired a new position in shares of Sotera Health during the first quarter worth about $266,000. BNP Paribas Financial Markets acquired a new position in shares of Sotera Health during the fourth quarter worth about $208,000. Principal Financial Group Inc. lifted its stake in shares of Sotera Health by 0.3% during the first quarter. Principal Financial Group Inc. now owns 352,388 shares of the company's stock worth $4,109,000 after purchasing an additional 1,037 shares in the last quarter. Finally, Ananym Capital Management LP acquired a new position in shares of Sotera Health during the fourth quarter worth about $13,680,000. Hedge funds and other institutional investors own 91.03% of the company's stock.

Sotera Health Stock Up 1.0%

NASDAQ SHC traded up $0.17 on Friday, hitting $16.37. 1,031,549 shares of the stock traded hands, compared to its average volume of 1,765,369. The stock has a 50-day moving average of $12.87 and a 200 day moving average of $12.26. Sotera Health Company has a twelve month low of $9.53 and a twelve month high of $17.08. The company has a market capitalization of $4.65 billion, a P/E ratio of 204.65 and a beta of 1.81. The company has a current ratio of 2.47, a quick ratio of 2.23 and a debt-to-equity ratio of 4.49.

Sotera Health (NASDAQ:SHC - Get Free Report) last announced its quarterly earnings data on Friday, August 8th. The company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.03. The firm had revenue of $294.34 million for the quarter, compared to analysts' expectations of $275.81 million. Sotera Health had a return on equity of 39.42% and a net margin of 2.14%.Sotera Health's revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.19 earnings per share. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. As a group, analysts expect that Sotera Health Company will post 0.61 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research firms recently commented on SHC. The Goldman Sachs Group upgraded Sotera Health from a "neutral" rating to a "buy" rating and boosted their price target for the stock from $14.00 to $17.00 in a research note on Monday, May 5th. Wall Street Zen upgraded Sotera Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 16th. Finally, Barclays reiterated an "overweight" rating on shares of Sotera Health in a research note on Friday, August 8th. Four equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $16.00.

Insider Transactions at Sotera Health

In related news, insider Michael P. Rutz sold 126,611 shares of the stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $16.38, for a total value of $2,073,888.18. Following the completion of the transaction, the insider directly owned 450,204 shares of the company's stock, valued at $7,374,341.52. This represents a 21.95% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 47.55% of the stock is owned by company insiders.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.